These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28011628)

  • 21. Regulation of HIF by the von Hippel-Lindau tumour suppressor: implications for cellular oxygen sensing.
    Mole DR; Maxwell PH; Pugh CW; Ratcliffe PJ
    IUBMB Life; 2001 Jul; 52(1-2):43-7. PubMed ID: 11795592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypoxia-Inducible Factor α and Hif-prolyl Hydroxylase Characterization and Gene Expression in Short-Time Air-Exposed Mytilus galloprovincialis.
    Giannetto A; Maisano M; Cappello T; Oliva S; Parrino V; Natalotto A; De Marco G; Barberi C; Romeo O; Mauceri A; Fasulo S
    Mar Biotechnol (NY); 2015 Dec; 17(6):768-81. PubMed ID: 26277612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imaging of HIF-1-active tumor hypoxia using a protein effectively delivered to and specifically stabilized in HIF-1-active tumor cells.
    Kudo T; Ueda M; Kuge Y; Mukai T; Tanaka S; Masutani M; Kiyono Y; Kizaka-Kondoh S; Hiraoka M; Saji H
    J Nucl Med; 2009 Jun; 50(6):942-9. PubMed ID: 19443598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased activation of the hypoxia-inducible factor pathway in varicose veins.
    Lim CS; Kiriakidis S; Paleolog EM; Davies AH
    J Vasc Surg; 2012 May; 55(5):1427-39. PubMed ID: 22277691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mouse model for noninvasive imaging of HIF prolyl hydroxylase activity: assessment of an oral agent that stimulates erythropoietin production.
    Safran M; Kim WY; O'Connell F; Flippin L; Günzler V; Horner JW; Depinho RA; Kaelin WG
    Proc Natl Acad Sci U S A; 2006 Jan; 103(1):105-10. PubMed ID: 16373502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prolyl hydroxylases 2 and 3 act in gliomas as protective negative feedback regulators of hypoxia-inducible factors.
    Henze AT; Riedel J; Diem T; Wenner J; Flamme I; Pouyseggur J; Plate KH; Acker T
    Cancer Res; 2010 Jan; 70(1):357-66. PubMed ID: 20028863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modeling the dynamics of hypoxia inducible factor-1α (HIF-1α) within single cells and 3D cell culture systems.
    Leedale J; Herrmann A; Bagnall J; Fercher A; Papkovsky D; Sée V; Bearon RN
    Math Biosci; 2014 Dec; 258():33-43. PubMed ID: 25245610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcriptional divergence of the duplicated hypoxia-inducible factor alpha genes in zebrafish.
    Rytkönen KT; Prokkola JM; Salonen V; Nikinmaa M
    Gene; 2014 May; 541(1):60-6. PubMed ID: 24613281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human hormone-refractory prostate cancers can harbor mutations in the O(2)-dependent degradation domain of hypoxia inducible factor-1alpha (HIF-1alpha).
    Anastasiadis AG; Ghafar MA; Salomon L; Vacherot F; Benedit P; Chen MW; Shabsigh A; Burchardt M; Chopin DK; Shabsigh R; Buttyan R
    J Cancer Res Clin Oncol; 2002 Jul; 128(7):358-62. PubMed ID: 12136249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The oxygen sensor factor-inhibiting hypoxia-inducible factor-1 controls expression of distinct genes through the bifunctional transcriptional character of hypoxia-inducible factor-1alpha.
    Dayan F; Roux D; Brahimi-Horn MC; Pouyssegur J; Mazure NM
    Cancer Res; 2006 Apr; 66(7):3688-98. PubMed ID: 16585195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a novel small-molecule inhibitor of the hypoxia-inducible factor 1 pathway.
    Tan C; de Noronha RG; Roecker AJ; Pyrzynska B; Khwaja F; Zhang Z; Zhang H; Teng Q; Nicholson AC; Giannakakou P; Zhou W; Olson JJ; Pereira MM; Nicolaou KC; Van Meir EG
    Cancer Res; 2005 Jan; 65(2):605-12. PubMed ID: 15695405
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypoxia-inducible factor prolyl-hydroxylase: purification and assays of PHD2.
    Hewitson KS; Schofield CJ; Ratcliffe PJ
    Methods Enzymol; 2007; 435():25-42. PubMed ID: 17998047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of hypoxia inducible factor-1α on P311 and its influence on the migration of murine epidermal stem cells].
    Xu ZD; Li HS; Wang S; He WF; Wu J; Luo GX
    Zhonghua Shao Shang Za Zhi; 2017 May; 33(5):287-294. PubMed ID: 28651420
    [No Abstract]   [Full Text] [Related]  

  • 34. HIF-1-regulated vasoactive systems are differentially involved in acute hypoxic stress responses of the developing brain of newborn mice and are not affected by levetiracetam.
    Trollmann R; Schneider J; Keller S; Strasser K; Wenzel D; Rascher W; Ogunshola OO; Gassmann M
    Brain Res; 2008 Mar; 1199():27-36. PubMed ID: 18281021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell-type-specific regulation of degradation of hypoxia-inducible factor 1 alpha: role of subcellular compartmentalization.
    Zheng X; Ruas JL; Cao R; Salomons FA; Cao Y; Poellinger L; Pereira T
    Mol Cell Biol; 2006 Jun; 26(12):4628-41. PubMed ID: 16738327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The importin α/β-specific inhibitor Ivermectin affects HIF-dependent hypoxia response pathways.
    Kosyna FK; Nagel M; Kluxen L; Kraushaar K; Depping R
    Biol Chem; 2015 Dec; 396(12):1357-67. PubMed ID: 26351913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of an oxygen/redox-dependent degradation domain of hypoxia-inducible factor alpha (HIF-alpha) proteins.
    Srinivas V; Zhang LP; Zhu XH; Caro J
    Biochem Biophys Res Commun; 1999 Jul; 260(2):557-61. PubMed ID: 10403805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The combination of hypoxia-response enhancers and an oxygen-dependent proteolytic motif enables real-time imaging of absolute HIF-1 activity in tumor xenografts.
    Harada H; Kizaka-Kondoh S; Itasaka S; Shibuya K; Morinibu A; Shinomiya K; Hiraoka M
    Biochem Biophys Res Commun; 2007 Sep; 360(4):791-6. PubMed ID: 17624305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of the oxygen-dependent degradation domain in a hypoxia-inducible gene expression system in vascular endothelial growth factor gene therapy.
    Jin H; Liu ML; Kim HA; Lee M; An S; Oh J; Cho J; Yi S; Kim K; Yoon D; Ha Y
    Spine (Phila Pa 1976); 2009 Dec; 34(26):E952-8. PubMed ID: 20010384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current advances in the novel functions of hypoxia-inducible factor and prolyl hydroxylase in invertebrates.
    Wang L; Cui S; Ma L; Kong L; Geng X
    Insect Mol Biol; 2015 Dec; 24(6):634-48. PubMed ID: 26387499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.